Daniel Elger joins e-Therapeutics
June 13, 2011Research and Development, Sales and Marketing appointment, research and development, sales and marketing
UK and India-based e-Therapeutics has appointed Dr Daniel Elger as chief financial officer. He joins the drug discovery company from …
Networks in Health appoints Beverly Stainsby
June 13, 2011Sales and Marketing appointment, sales and marketing
Beverly Stainsby has joined Networks in Health, an alliance of online doctors’ communities, as international account director. She joins from …
European pharma’s compliance challenge
June 13, 2011Sales and Marketing global regulatory landscape, regulatory affairs, regulatory compliance
Life Sciences companies across Europe are facing a series of emerging global legislation and increased regulatory enforcement, designed to prevent …
GSK’s epilepsy treatment Potiga wins US approval
June 13, 2011Sales and Marketing GSK, Potiga, Trobalt, Valeant, epilepsy
The FDA has approved GlaxoSmithKline and Valeant’s epilepsy treatment Potiga, but the drug will require further review before it can …
France pulls Takeda diabetes drugs after cancer fears
June 13, 2011Sales and Marketing Actos, Competact, EMA, Takeda
The French medicines agency has moved to prevent two Takeda diabetes drugs from being prescribed after fears they could increase …
New Priorclave Autoclave Bound to be First
June 10, 2011Manufacturing and Production
Although it provides for increased loading, the combination of forced air cooling reduces cycle times and automatic timed free-steaming improves …
Digital Pharma: European doctors turn to the social web
June 10, 2011Medical Communications Digital Pharma blog, digital doctors, social media
European GPs are making increasing use of the social web and new research has shown Wikipedia to be the most …
Rasi nominated to be EMA chief
June 10, 2011Research and Development, Sales and Marketing EMA, Guido Rasi, Thomas Lönngren
The European Medicines Agency has nominated Italy’s Guido Rasi to be its next head, after a protracted and messy search. …
GPs warn the government: don’t cut NHS off at the legs
June 10, 2011Health and Social Care Bill, NHS reforms
The government’s beleaguered reform programme could amputate whole parts of the NHS and must be heavily amended if not fully …
EU red tape blamed for decline in UK clinical trials
June 10, 2011Research and Development UK clinical research, clinical trials
Medical and pharma groups have blamed European Union red tape for the decline in the UK as a location for …
ApotheCom ScopeMedical expands team
June 10, 2011Medical Communications ApotheCom ScopeMedical, medical communications
Kent-based healthcare communications agency ApotheCom ScopeMedical has expanded its team, appointing new medical and project management staff. Joining the Huntsworth …
Eurocom wins dermal filler account
June 10, 2011Medical Communications Eurocom, medical communications
Eurocom Healthcare Communications has been appointed to manage marketing communications for Ellansé, a novel family of dermal fillers. The London-based …
Red Door appoints Claire Pay
June 10, 2011Medical Communications appointment, medical communications
Red Door Communications has bolstered its consumer heath team with the addition of Claire Pay, who joins the healthcare agency …
Validus Pharmaceuticals Deploys Veeva iRep to US Salesforce
June 9, 2011PLEASANTON, CA — June 9, 2011
Lilly promotes Andrew Hotchkiss
June 9, 2011Research and Development, Sales and Marketing appointment, research and development, sales and marketing
Lilly has appointed Andrew Hotchkiss president of its operations in Australia, Canada and Europe. Andrew has been with the company …
Daiichi Sankyo: Europe poses huge challenge for pharma
June 9, 2011Research and Development, Sales and Marketing Cancer, Daiichi Sankyo, pricing
Japanese pharma company Daiichi Sankyo is expanding its European operations, creating a new oncology business unit. But outlining its plans …
NICE thumbs up for Allergan’s Ozurdex
June 9, 2011Sales and Marketing Allergan, BRVO, CVRO, NICE, Ozurdex
In draft guidance NICE has recommended the use of Allergan’s eye treatment Ozurdex.NICE’s final decision on Ozurdex (dexamethasone) is expected …
Merck Serono signs neurodegenerative collaboration
June 9, 2011Research and Development Affectis Pharmaceuticals, Merck Serono
Merck Serono has struck a deal with biotech firm Affectis Pharmaceuticals to develop oral neurodegeneration compounds. The companies will commercialise …
The Pharmafocus Interview: Richard Barker
June 9, 2011Research and Development, Sales and Marketing ABPI, Dr Richard Barker, vita
Dr Richard Barker has been at the helm of the UK pharma industry for over six years, but is now …
Price transparency and timing at risk, warns EFPIA
June 9, 2011Sales and Marketing Drug pricing, EFPIA, medicines pricing, pricing
Europe’s pharmaceutical industry has warned that a review of EU law could undermine the pricing and reimbursement of medicines. The …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
